The Non-motor Symptom Complex of Parkinson's Disease: a Comprehensive Assessment is Essential

Overview

Journal Curr Neurol Neurosci Rep

Specialty Neurology

Date 2005 Jul 1

PMID 15987611

Citations 60

Authors

K Ray Chaudhuri

L Yates

P Martinez-Martin

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease (PD) is a progressive disease that usually affects the motor system but is also associated with a non-motor symptom (NMS) complex that ranges from dribbling saliva, constipation, depression, sleep disorders, apathy, hallucinations, and dementia. These features contribute significantly to morbidity and institutionalization, more than quadrupling the cost of care. Furthermore, recent evidence suggests that NMS such as constipation, olfaction, rapid eye movement behavior disorder, fatigue, and depression may be markers of a preclinical stage of PD. PD-NMS are not well recognized in clinical practice and part of the reason is the lack of any instrument that aims to assess the complex range of NMS of PD in a unified and integrated manner. Recently, an international, multidisciplinary PD-NMS group has developed an integrated questionnaire and scale to assess NMS of PD in a comprehensive manner. This will help improve care and treatment of PD in the future.

Citing Articles

Impulse control disorders and other non-motor symptoms in Sri Lankan patients with Parkinson's disease.

Herath H, Wijayawardhana K, Wickramarachchi U, Senanayake S, Rodrigo C, Senanayake B PLoS One. 2024; 19(10):e0312342.

PMID: 39423191 PMC: 11488724. DOI: 10.1371/journal.pone.0312342.

Non-Motor Symptom Management: Insights into Adherence to Treatment Guidelines in Parkinson's Disease Patients.

Janz C, Timpka J, Rosqvist K, Paul G, Storch A, Odin P J Parkinsons Dis. 2024; 14(2):297-312.

PMID: 38217612 PMC: 10977407. DOI: 10.3233/JPD-230263.

Dopamine transporter binding in the brain is linked to irritable bowel syndrome in Parkinson's disease.

Murtomaki K, Joutsa J, Mertsalmi T, Jaakkola E, Makinen E, Levo R Brain Behav. 2023; 13(7):e3097.

PMID: 37254594 PMC: 10338780. DOI: 10.1002/brb3.3097.

What are the modifiable factors of treatment burden and capacity among people with Parkinson's disease and their caregivers: A qualitative study.

Tan Q, Roberts H, Fraser S, Amar K, Ibrahim K PLoS One. 2023; 18(3):e0283713.

PMID: 36996125 PMC: 10062656. DOI: 10.1371/journal.pone.0283713.

Efficacy of herbal medicine treatment based on syndrome differentiation for Parkinson's disease: A systematic review and meta-analysis of randomized placebo-controlled clinical trials.

Jun P, Zhao H, Jung I, Kwon O, Han C, Won J Front Pharmacol. 2023; 14:1108407.

PMID: 36925641 PMC: 10012343. DOI: 10.3389/fphar.2023.1108407.

References

Karachi C, Yelnik J, Tande D, Tremblay L, Hirsch E, Francois C . The pallidosubthalamic projection: an anatomical substrate for nonmotor functions of the subthalamic nucleus in primates. Mov Disord. 2004; 20(2):172-80. DOI: 10.1002/mds.20302. View

Okun M, McDonald W, DeLong M . Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity. Arch Neurol. 2002; 59(5):807-11. DOI: 10.1001/archneur.59.5.807. View

Johns M . A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991; 14(6):540-5. DOI: 10.1093/sleep/14.6.540. View

Ramaker C, Marinus J, Stiggelbout A, Van Hilten B . Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord. 2002; 17(5):867-76. DOI: 10.1002/mds.10248. View

Grandas F, Iranzo A . Nocturnal problems occurring in Parkinson's disease. Neurology. 2004; 63(8 Suppl 3):S8-11. DOI: 10.1212/wnl.63.8_suppl_3.s8. View

Guttman M, Slaughter P, Theriault M, DeBoer D, Naylor C . Burden of parkinsonism: a population-based study. Mov Disord. 2003; 18(3):313-319. DOI: 10.1002/mds.10333. View

Chaudhuri K . Nocturnal symptom complex in PD and its management. Neurology. 2003; 61(6 Suppl 3):S17-23. DOI: 10.1212/wnl.61.6_suppl_3.s17. View

Shulman L, Taback R, Rabinstein A, Weiner W . Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord. 2002; 8(3):193-7. DOI: 10.1016/s1353-8020(01)00015-3. View

Abbott R, Petrovitch H, White L, Masaki K, Tanner C, Curb J . Frequency of bowel movements and the future risk of Parkinson's disease. Neurology. 2001; 57(3):456-62. DOI: 10.1212/wnl.57.3.456. View

10.

Newman A, Spiekerman C, Enright P, Lefkowitz D, Manolio T, Reynolds C . Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc. 2000; 48(2):115-23. DOI: 10.1111/j.1532-5415.2000.tb03901.x. View

11.

Goetz C, Stebbins G . Risk factors for nursing home placement in advanced Parkinson's disease. Neurology. 1993; 43(11):2227-9. DOI: 10.1212/wnl.43.11.2227. View

12.

Ahlskog J . Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease. Mov Disord. 2004; 20(3):271-82. DOI: 10.1002/mds.20362. View

13.

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

14.

Hely M, Morris J, Reid W, Trafficante R . Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord. 2004; 20(2):190-9. DOI: 10.1002/mds.20324. View

15.

. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord. 2002; 17(1):60-7. DOI: 10.1002/mds.10010. View

16.

Chaudhuri K, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R . The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2002; 73(6):629-35. PMC: 1757333. DOI: 10.1136/jnnp.73.6.629. View

17.

Parkinson J . An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002; 14(2):223-36; discussion 222. DOI: 10.1176/jnp.14.2.223. View

18.

Karlsen K, Larsen J, Tandberg E, Maeland J . Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999; 66(4):431-5. PMC: 1736304. DOI: 10.1136/jnnp.66.4.431. View

19.

Scherder E, Oosterman J, Swaab D, Herr K, Ooms M, Ribbe M . Recent developments in pain in dementia. BMJ. 2005; 330(7489):461-4. PMC: 549660. DOI: 10.1136/bmj.330.7489.461. View

20.

Marinus J, Visser M, Martinez-Martin P, van Hilten J, Stiggelbout A . A short psychosocial questionnaire for patients with Parkinson's disease: the SCOPA-PS. J Clin Epidemiol. 2003; 56(1):61-7. DOI: 10.1016/s0895-4356(02)00569-3. View